Anthropic launches powerful AI coding model Claude Sonnet 4.5, boosting enterprise and regulated-industry use.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.
Anthropic launches powerful AI coding model Claude Sonnet 4.5, boosting enterprise and regulated-industry use.
AstraZeneca proposes a direct NYSE listing to broaden its global investor base and simplify access for U.S. investors, while the company's Enhertu drug shows promising results.